| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037852A2 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | WO2001037832A2 Combination of riluzole and gabapentin and use thereof as medicine |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000047194A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | DE19957156A1 New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders |
| 05/31/2001 | DE19956791A1 New 2-heterocyclyl-4-arylsulfonyl-5-amino-oxazole derivatives useful in treatment of central nervous system disorders and as pesticides |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392327A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2392217A1 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | CA2391575A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2389679A1 Novel sulfonyloxazolamines |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103267A1 Botulinum toxins for treating various disorders and associated pain |
| 05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
| 05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102586A1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis |
| 05/30/2001 | CN1297432A Substd. amides, their production and their use |
| 05/30/2001 | CN1296849A Medicine for dispersing stasis and conditioning tendon |
| 05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/25/2001 | WO2001036423A1 Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors |
| 05/25/2001 | WO2001036419A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/25/2001 | WO2001036398A1 Benzoxa- and benzthiazoles |
| 05/25/2001 | WO2001036388A1 Aza compounds having neuronal activity |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2390071A1 Aza compounds having neuronal activity |
| 05/25/2001 | CA2387809A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100769A1 Aminomethylcarboxylic acid derivatives |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100471A1 Compressed compositions comprising clarified xanthan gum |
| 05/23/2001 | EP1100462A2 Methods of ophthalmic administration |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034566A2 Protease inhibitors |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034159A1 Protease inhibitors |
| 05/17/2001 | WO2001034158A1 Protease inhibitors |
| 05/17/2001 | WO2001034157A1 Protease inhibitors |
| 05/17/2001 | WO2001034141A1 Il-8 receptor antagonists |
| 05/17/2001 | WO2001034136A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390797A1 Methods for the treatment and prevention of neurodegenerative conditions |
| 05/17/2001 | CA2390524A1 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/16/2001 | EP1099445A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1098906A1 Peptide analogues of pacap |
| 05/16/2001 | EP1098894A1 Fkbp inhibitors |
| 05/16/2001 | EP1098655A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 05/16/2001 | EP0842165B1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1294911A Substituted nitrobenzene derivative for medicine and other use |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | CA2310845C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/15/2001 | CA2180011C Botulinum toxins for treating sweating |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032654A2 Novel heterocyclic compounds and their use as medicines |
| 05/10/2001 | WO2001032653A1 Heterocyclic substituted pyrazolones |